This study assesses feasibility and patient acceptability of using a Fitbit to monitor step count and heart rate in transfusion dependent patients with myelodysplastic syndrome. Information from this study may help researchers understand if there is any correlation between activity level and anemia.
This study assesses feasibility and patient acceptability of using a Fitbit to monitor step count and heart rate in transfusion dependent patients with myelodysplastic syndrome. Information from this study may help researchers understand if there is any correlation between activity level and anemia.
Study Type
OBSERVATIONAL
Wear activity monitor (Fitbit)
Undergo collection of blood samples
Complete questionnaires
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Accrual rate
accrual rate will be measured by counting subjects
Time frame: Up to 90 days
Acceptability
Acceptability will be measured by a short survey
Time frame: Up to 90 days
compliance with device
compliance with device (80% of the 90-day intervention time)
Time frame: Up to 90 days
retention rate
retention rate of subjects will be measured by counting at 90 days
Time frame: Up to 90 days
Acceptability
Acceptability will be measured by an interview addressing participant satisfaction
Time frame: Up to 90 days
Daily step count
Daily step count
Time frame: Up to 90 days
Average daily resting heart rate
average daily resting heart rate
Time frame: Up to 90 days
Fact-An score (assessed twice a week),
Fact-An score (assessed twice a week),
Time frame: Up to 90 days
Hemoglobin level measured by CBC twice a week
Hemoglobin level measured by CBC twice a week
Time frame: Up to 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Complete questionnaires